HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.

Mostrar outras versões (1)

This study investigated the effects of 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) acetic acid (IOX3), a selective small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylases, on mouse brains subject to transient focal cerebral ischaemia. Male, 8- to 12-week-old C57/B6 mice w...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Chen, R, Ogunshola, O, Yeoh, K, Jani, A, Papadakis, M, Nagel, S, Schofield, C, Buchan, A
Formato:	Journal article
Idioma:	English
Publicado em:	2014

Registros relacionados

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
por: Chen, R, et al.
Publicado em: (2014)

Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice.
por: Chen, R, et al.
Publicado em: (2012)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
por: Maria Savyuk, et al.
Publicado em: (2020-07-01)

Regulation of HIF: prolyl hydroxylases.
por: Stolze, I, et al.
Publicado em: (2006)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
por: Singh, A, et al.
Publicado em: (2020)

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia.
por: Sutherland, B, et al.
Publicado em: (2011)

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia
por: Sutherland, B, et al.
Publicado em: (2011)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
por: Mole, D, et al.
Publicado em: (2003)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
por: McNeill, L, et al.
Publicado em: (2002)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
por: Schlemminger, I, et al.
Publicado em: (2003)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.
por: Nagel, S, et al.
Publicado em: (2011)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats
por: Nagel, S, et al.
Publicado em: (2011)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
por: Flashman, E, et al.
Publicado em: (2010)

Therapeutic manipulation of the HIF hydroxylases.
por: Nagel, S, et al.
Publicado em: (2010)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
por: Cockman, M, et al.
Publicado em: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
por: Matthew E Cockman, et al.
Publicado em: (2019-09-01)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
por: Tuckerman, JR, et al.
Publicado em: (2004)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
por: Chan, M, et al.
Publicado em: (2016)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
por: Chowdhury, R, et al.
Publicado em: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
por: Chowdhury, R, et al.
Publicado em: (2016)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
por: Richardson, NL, et al.
Publicado em: (2021)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
por: Rasheduzzaman Chowdhury, et al.
Publicado em: (2016-08-01)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
por: Yeh, TL, et al.
Publicado em: (2017)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
por: Moritz J. Strowitzki, et al.
Publicado em: (2021-04-01)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
por: Yeoh, K, et al.
Publicado em: (2013)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
por: Wijeyekoon, JB
Publicado em: (2013)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
por: Andrey A. Poloznikov, et al.
Publicado em: (2021-01-01)

USE OF PROLYL HYDROXYLASE INHIBITORS TO INDUCE HIF-RELATED METABOLIC CHANGES AND INCREASE C-KIT EXPRESSION IN CARDIOSPHERE-DERIVED CELLS
por: Tan, S, et al.
Publicado em: (2011)

Inhibition of a viral prolyl hydroxylase
por: Langley, G, et al.
Publicado em: (2019)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
por: Astuti, D, et al.
Publicado em: (2010)

Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia.
por: Nagel, S, et al.
Publicado em: (2012)

Relative Contribution of Prolyl Hydroxylase-Dependent and -Independent Degradation of HIF-1alpha by Proteasomal Pathways in Cerebral Ischemia
por: Yomna Badawi, et al.
Publicado em: (2017-05-01)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
por: Mayer, M, et al.
Publicado em: (2018)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
por: Holt-Martyn, JP, et al.
Publicado em: (2019)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
por: Lippl, K
Publicado em: (2018)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
por: Masson, N, et al.
Publicado em: (2003)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
por: Takahiro Kambara, et al.
Publicado em: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
por: Kiichi Hirota
Publicado em: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
por: Kilian B. Kennel, et al.
Publicado em: (2022-11-01)

Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
por: Savyuk, Maria Olegovna, et al.
Publicado em: (2021-05-01)